DC
Therapeutic Areas
Minerva Biotechnologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MUC1*-Targeted CAR T | Solid Tumors (e.g., Breast, Lung, Ovarian, Pancreatic) | Pre-clinical |
| MUC1*-Targeted ADC | Solid Tumors | Pre-clinical |
| AlphaSTEM® Platform | Stem Cell Expansion & Differentiation | Platform/Research |